3rd Quarter - Report

MAD GLOBAL STRATEGY for ADNEURIS THERAPEUTICS, INC.

Firm
Client
Income
$15,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Education on new drug seeking FDA approval

LobbyistCovered position, as disclosed
MIMI BRANIFF Senate Energy Committee- Special Counsel; Senate Commerce Committee- Deputy Chief Counsel; Senate Appropriations Committee- Counsel; Senator Ted Stevens- Legislative Assistant

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.